Skip to main content

Table 1 Types of cancers and the associated chemotherapy regimens [2]

From: Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program

Type of Cancer (incidence ranking)

Associated chemotherapy regimen

Males

 Basal cell carcinoma

Topical Fluorouracil

 Prostate Cancer

Docetaxel and Prednisone

 Squamous cell carcinoma

5-Flourouracil, Cisplatin or Carboplatin

 Non-small cell lung cancer

Cisplatin, and Vinorelbine, or Docetaxel, or Gemcitabine, or Etoposide

 Small cell lung cancer

Cisplatin or Carboplatin, Etoposide

 Oesophageal Cancer

Cisplatin, 5-Fluorouracil, Docetaxel, Oxaliplatin, Capecitabine

Females

 Breast

Doxorubicin/Cycloplosphamide, Paclitaxel, Trastuzumab, Carboplatin, 5-Fluorouracil, Epirubicin

 Cervix

Cisplatin, Paclitaxel, Carboplatin, Gemcitabine

 Basal cell carcinoma

Topical Fluorouracil

 Squamous cell carcinoma

5-Flourouracil, Cisplatin or Carboplatin

  Colon

Oxaliplatin, Capecitabine, 5-Fluorouracil